Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rating rater improvement: a method for estimating increased effect size and reduction of clinical trial costs.

× No keyword cloud information.

10 in total

Review 1. Alzheimer's disease drug development in 2008 and beyond: problems and opportunities.

Authors: Robert E Becker; Nigel H Greig
Journal: Curr Alzheimer Res Date: 2008-08 Impact factor: 3.498

2. Increasing the success rate for Alzheimer's disease drug discovery and development.

Authors: Robert E Becker; Nigel H Greig
Journal: Expert Opin Drug Discov Date: 2012-03-23 Impact factor: 6.098

3. Fire in the ashes: can failed Alzheimer's disease drugs succeed with second chances?

Authors: Robert E Becker; Nigel H Greig
Journal: Alzheimers Dement Date: 2012-03-30 Impact factor: 21.566

Review 4. Why so few drugs for Alzheimer's disease? Are methods failing drugs?

Authors: R E Becker; N H Greig
Journal: Curr Alzheimer Res Date: 2010-11 Impact factor: 3.498

Review 5. Lost in translation: neuropsychiatric drug development.

Authors: Robert E Becker; Nigel H Greig
Journal: Sci Transl Med Date: 2010-12-08 Impact factor: 17.956

6. Phenserine efficacy in Alzheimer's disease.

Authors: Bengt Winblad; Ezio Giacobini; Lutz Frölich; Lawrence T Friedhoff; Gosse Bruinsma; Robert E Becker; Nigel H Greig
Journal: J Alzheimers Dis Date: 2010 Impact factor: 4.472

Review 7. Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices?

Authors: Robert E Becker; Nigel H Greig; Ezio Giacobini
Journal: J Alzheimers Dis Date: 2008-10 Impact factor: 4.472

8. Neuropsychiatric clinical trials: should they accommodate real-world practices or set standards for clinical practices?

Authors: Robert E Becker; Nigel H Greig
Journal: J Clin Psychopharmacol Date: 2009-02 Impact factor: 3.153

Review 9. Alzheimer's disease drug development: old problems require new priorities.

Authors: Robert E Becker; Nigel H Greig
Journal: CNS Neurol Disord Drug Targets Date: 2008-12 Impact factor: 4.388

10. Magnitude of change with antidepressants and placebo in antidepressant clinical trials using structured, taped and appraised rater interviews (SIGMA-RAPS) compared to trials using traditional semi-structured interviews.

Authors: Arif Khan; James Faucett; Walter A Brown
Journal: Psychopharmacology (Berl) Date: 2014-04-26 Impact factor: 4.530

10 in total